Find the Perfect Plan for Your Investment Journey
B
Latest price
52 Week Range
€1.92 - €4.35
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | €38.75M |
EV | €32.63M |
Shares Outstanding | 15.19M |
Beta | 0.67 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €3.20 |
P/E 2025E | 17.18x |
P/Revenue 2025E | 2.30x |
Revenue | 15.20% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | 0.50% |
Revenue | 15.80% |
EPS | 7.30% |
Operating Cash Flow | 83.20% |
Free Cash Flow | 147.80% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | 13.53% |
ROE 2025E | 17.00% |
ROCE 2024 | 23.76% |
DPS 2025E | €0.04 |
Payout Ratio 2025E | 26.67% |
Div. Yield 2025E | 1.55% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
Biohit Oyj
BIOBV
Sector
Healthcare
Industry
Biotechnology
CEO
Hahtela, Jussi
Employees
46
Website
www.biohithealthcare.comIPO Date
2000-01-03
Headquarters
Laippatie 1, Helsinki, Uusimaa, 00880, Finland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved